January 21, 2025 Save the Date: CGIC Returns to D.C. this September We are thrilled to invite you to the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC)...
November 14, 2024 Advanced in Vitro Modelling of Neuromuscular Diseases and Therapeutics Join this webinar to explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering...
November 13, 2024 C-Path Announces Global Evidence in Medicine for Parkinson’s Disease (GEM‑PD) Initiative C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..
November 7, 2024 C-Path Announces Key Leadership Appointments in Neurodegenerative Disease Research Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD.
September 12, 2024 C-Path’s Inaugural Global Impact Conference Charts the Future of Drug Development C-Path successfully concluded its inaugural Global Impact Conference (CGIC) on September 11, 2024.
September 9, 2024 FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson’s and Related Diseases FDA) encouraged scientists and drug developers to use the alpha-synuclein seed amplification assay (αSyn-SAA) biomarker...
August 12, 2024 C-Path Welcomes CuraSen As Newest CPP Member C-Path is thrilled to welcome CuraSen Therapeutics as the newest member of its Critical Path for Parkinson’s Consortium.
August 12, 2024 CPP CODR Database — Data Standards: Why are they needed? C-Path's Critical Path for Parkinson's (CPP) Consortium consultant Anne Pedata led this webinar on...
July 23, 2024 DATAcc by DiMe Expands Library of Digital Measurement Products to Include Parkinson’s Disease Today, the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe), in partnership....
June 24, 2024-June 25, 2024 C-Path’s Stephenson to Serve as Co-panelist for FNIH Digital Technologies Summit C-Path's Executive Director, Critical Path for Parkinson's (CPP) Consortium, Diane Stephenson will join as a...